Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04183218

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:29:05.441181+00:00

Published At

2026-04-21T00:00:00+00:00

Record Updated At

2026-04-21

Results Posted At

2026-04-21

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8", "Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8", "Clinical Stage I Esophageal Adenocarcinoma AJCC v8", "Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8", "Clinical Stage II Esophageal Adenocarcinoma AJCC v8", "Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8", "Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8", "Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8", "Clinical Stage III Esophageal Adenocarcinoma AJCC v8", "Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8", "Localized Esophageal Carcinoma", "Localized Lung Carcinoma", "Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8", "Pathologic Stage I Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8", "Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8", "Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8", "Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage II Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8", "Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8", "Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8", "Pathologic Stage III Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8", "Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8", "Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8", "Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8", "Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8", "Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8", "Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8", "Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8", "Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8", "Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8", "Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8", "Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8", "Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8", "Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8", "Stage 0 Lung Cancer AJCC v8", "Stage I Lung Cancer AJCC v8", "Stage IA1 Lung Cancer AJCC v8", "Stage IA2 Lung Cancer AJCC v8", "Stage IA3 Lung Cancer AJCC v8", "Stage IB Lung Cancer AJCC v8", "Stage II Lung Cancer AJCC v8", "Stage IIA Lung Cancer AJCC v8", "Stage IIB Lung Cancer AJCC v8", "Stage III Lung Cancer AJCC v8", "Stage IIIA Lung Cancer AJCC v8", "Stage IIIB Lung Cancer AJCC v8", "Stage IIIC Lung Cancer AJCC v8"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-04-21"

protocolSection.identificationModule.nctId

"NCT04183218"

protocolSection.identificationModule.officialTitle

"Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2026-04-21"

Study condition terms

• Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage I Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage II Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage III Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Localized Esophageal Carcinoma (protocolSection.conditionsModule.conditions)
• Localized Lung Carcinoma (protocolSection.conditionsModule.conditions)
• Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage I Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage II Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage III Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage 0 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage I Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IA1 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IA2 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IA3 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage II Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIA Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIA Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIC Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.